Hep C Drug Stocks in the Spotlight

Description:

According to Adam Feuerstein, "Biotech and drug investors with interest in emerging treatments for hepatitis C turn their attention this week to the European Association for the Study of the Liver (EASL) annual meeting, which kicks off Weds. March 30." Read more here.

>>Also: Top-Rated Biotech Stocks

>>Also: 40 Stocks Analysts Are Insanely Bullish About

Most Viewed Portfolios

View All

Articles

5 Breakout Stocks Under $10 Set to Soar

08.22.14 | 02:48 PM

DELAFIELD, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for under $10 a share don't experience...

4 Stocks Under $10 to Trade for Breakouts

08.22.14 | 07:00 AM

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percenta...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter